Physician profile

Saroj Gupta

Physical Medicine & Rehabilitation · Jamaica, NY

NPI 1396749214

$1,532.96

in general payments reported to CMS, 2019-2025

10 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$472.91

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Glaxosmithkline, LLC. $496.47 2019-2023 Shingrix
Abbott Laboratories $150.00 2024 Freestyle Libre 3
Medtronic, INC. $125.00 2022
Pfizer INC. $122.55 2019
Novo Nordisk INC $122.42 2022
Pacira Pharmaceuticals Incorporated $122.19 2024 Exparel
Boston Scientific Corporation $120.10 2020
Janssen Pharmaceuticals, INC $114.64 2022
Gilead Sciences, INC. $83.63 2019
Intuitive Surgical, INC. $75.96 2023 Da Vinci Surgical System

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Saroj Gupta

$1,532.96

in general payments reported 2019-2025

Years
2019-2024
Top company
Glaxosmithkline, LLC.

https://glasscript.com/doctor/688068/saroj-gupta

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.